CERo Therapeutics Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236news2024-06-06T17:58:46+00:00June 6th, 2024|Medical Device News Magazine|
New US Headquarters Opened By Mass Photometry Pioneers Refeynnews2024-06-06T17:54:14+00:00June 6th, 2024|Medical Device News Magazine|
Tianlong Promotes Environmental Sustainability and Hygiene Monitoring with its Biolum Portable ATP Hygiene Monitoring System Seriesnews2024-06-06T08:47:46+00:00June 6th, 2024|Medical Device News Magazine|
Alchemab advances a novel antibody with potential in Parkinson’s disease with support from The Michael J. Fox Foundationnews2024-06-06T08:36:11+00:00June 6th, 2024|Medical Device News Magazine|
MilliporeSigma Announces Completion of Schnelldorf Distribution Center Expansionnews2024-06-06T08:17:12+00:00June 6th, 2024|Medical Device News Magazine|
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substancenews2024-05-29T13:45:41+00:00May 29th, 2024|Medical Device News Magazine|
Abu Dhabi Issues First BioTech Inventor-Class Golden Visa to Catalyze “Made-In-Abu-Dhabi IP” to Rockefeller University Inventor Dr Kambiz Shekdar, PhDnews2024-05-24T16:27:41+00:00May 24th, 2024|Medical Device News Magazine|
Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startupsnews2024-05-23T19:21:04+00:00May 23rd, 2024|Medical Device News Magazine|
Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)news2024-05-15T13:02:51+00:00May 15th, 2024|Medical Device News Magazine|
AbbVie and Gilgamesh Pharmaceuticals | Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disordersnews2024-05-13T15:03:07+00:00May 13th, 2024|Medical Device News Magazine|